← Leaderboards
Lawrence H Schwartz
Sloan-Kettering Institute For Cancer Res
$9,739,750
Attributed
$18,407,238
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,407,238 · 7
By mechanism
U01$9,230,073 · 3
R01$8,800,907 · 3
R21$376,258 · 1
Top collaborators
- Binsheng Zhao11 shared
- Rene Bruno6 shared
- Michael L. Maitland6 shared
- Michael J Morris6 shared
- Amita Dave5 shared
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- George Sgouros$17,275,548
- Michael J Morris$6,941,101
- Vladimir Ponomarev$13,434,344
- Glenn Heller$7,155,475
- Richard J O'Reilly$17,498,839
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageBaseTumorMeasurementResponseLesionClinical TrialsBiological MarkersTumor BurdenImaging ModalityValidationAlgorithmsMalignant NeoplasmsX-Ray Computed TomographyDrug DevelopmentPositron-Emission TomographyChemotherapyFutureData SetPerformancePredictive ModelingNeoplasm MetastasisProgression-Free SurvivalsNon-Small-Cell Lung Carcinoma
Grant awards (35)
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer$765,415
R01 · FY2025 · CA · contact PI
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer$914,388
R01 · FY2024 · CA · contact PI
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer$974,889
R01 · FY2023 · CA · contact PI
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer$689,898
R01 · FY2022 · CA · contact PI
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer$566,084
U01 · FY2022 · CA · contact PI
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer$31,210
U01 · FY2022 · CA · contact PI
Quantitative imaging tools to derive DW-MRI oncological biomarkers$619,983
U01 · FY2021 · CA
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer$609,495
U01 · FY2021 · CA · contact PI
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer$197,785
R01 · FY2021 · CA · contact PI
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer$719,712
R01 · FY2020 · CA · contact PI
Quantitative imaging tools to derive DW-MRI oncological biomarkers$681,815
U01 · FY2020 · CA
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer$609,531
U01 · FY2020 · CA · contact PI
Computational modeling of tumor burden by CT to advance cancer therapeutics$558,237
R01 · FY2020 · CA
Quantitative imaging tools to derive DW-MRI oncological biomarkers$661,361
U01 · FY2019 · CA
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer$601,400
U01 · FY2019 · CA · contact PI
Computational modeling of tumor burden by CT to advance cancer therapeutics$556,187
R01 · FY2019 · CA
Quantitative imaging tools to derive DW-MRI oncological biomarkers$669,621
U01 · FY2018 · CA
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer$644,727
U01 · FY2018 · CA · contact PI
Computational modeling of tumor burden by CT to advance cancer therapeutics$573,026
R01 · FY2018 · CA
Quantitative imaging tools to derive DW-MRI oncological biomarkers$717,253
U01 · FY2017 · CA
Computational modeling of tumor burden by CT to advance cancer therapeutics$579,655
R01 · FY2016 · CA
Computational modeling of tumor burden by CT to advance cancer therapeutics$1,852
R01 · FY2016 · CA
Computational modeling of tumor burden by CT to advance cancer therapeutics$613,155
R01 · FY2015 · CA
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model$520,335
U01 · FY2015 · CA · contact PI
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model$520,533
U01 · FY2014 · CA · contact PI
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model$536,959
U01 · FY2013 · CA · contact PI
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model$583,741
U01 · FY2012 · CA · contact PI
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model$656,025
U01 · FY2011 · CA · contact PI
Advanced Anatomic and Functional Response Assessment in Lung Cancer$284,255
R01 · FY2011 · CA · contact PI
Advanced Anatomic and Functional Response Assessment in Lung Cancer$307,531
R01 · FY2010 · CA · contact PI
Advanced Anatomic and Functional Response Assessment in Lung Cancer$355,300
R01 · FY2009 · CA · contact PI
Advanced Anatomic and Functional Response Assessment in Lung Cancer$355,300
R01 · FY2008 · CA · contact PI
Advanced Anatomic and Functional Response Assessment in Lung Cancer$354,322
R01 · FY2007 · CA · contact PI
Computer Aided Liver Lesion Detection Algorithm$188,325
R21 · FY2005 · CA
Computer Aided Liver Lesion Detection Algorithm$187,933
R21 · FY2004 · CA